Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Good in vitro activity reported for Novartis PKC inhibitor

Jan. 12, 1998

Merck continues to devote extensive R&D efforts to FTase inhibitors

Jan. 12, 1998

New phosphatase inhibitors from the University of Pittsburgh

Jan. 9, 1998

New rationale elucidated for clinical evaluation of GW-506U in refractory hematologic malignancies

Jan. 9, 1998

New vitamin D conjugates disclosed by Clarion

Jan. 8, 1998

Protein farnesyltransferase inhibitors disclosed by Schering-Plough

Jan. 8, 1998

Photofrin approval sought in nine additional European countries

Jan. 7, 1998

Theratechnologies to begin clinical testing of leukemia Rx

Jan. 7, 1998

More on peptidomimetic protein farnesyltransferase inhibitors from Merck & Co.

Jan. 7, 1998

MMP inhibitor developed at Chiroscience enters clinical trials for cancer

Jan. 5, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...